Levosimendan cardioprotection in acutely β-1 adrenergic receptor blocked open chest pigs

Acta Anaesthesiologica Scandinavica

Volumn 54, Issue 1, 2010, Pages 103-110

  Metzsch, C ^a,b   Linner R ^a   Steen, S ^a   Liao, Q ^a   Algotsson, L ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCEROL; LACTIC ACID; LEVOSIMENDAN; METOPROLOL; MYOGLOBIN; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; EXPERIMENTAL PIG; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOTONIC AGENTS; CLINICAL PROTOCOLS; FEMALE; GLUCOSE; GLYCEROL; HEMODYNAMICS; HYDRAZONES; LACTIC ACID; MALE; METOPROLOL; MICRODIALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PYRIDAZINES; PYRUVIC ACID; SWINE; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 72249117543     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.02070.x     Document Type: Article

References (25)

1. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006 104 : 556 569.
2. Lehtonen L, Põder P. The utility of levosimendan in the treatment of heart failure. Ann Med 2007 39 : 2 17.
3. Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000 90 : 5 11.
4. Hein M, Roehl AB, Baumert JH, Scherer K, Steendijk P, Rossaint R. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction. Acta Anaesthesiol Scand 2009 53 : 941 948.
5. Tritapepe L, De Santis V, Vitale D, Guarracina F, Pellegrini F, Pietropaoli P, Singer M. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009 102 : 198 204.
6. Ibanez B, Prat-González S, Speidl WS, Vilahur G, Pinero A, Cimmino G, García MJ, Fuster V, Sanz J, Badimon JJ. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 2007 115 : 2909 2916.
7. Chen X, Minatoguchi S, Arai M, Wang N, Lu C, Narentuoya B, Uno Y, Misao Y, Takemura G, Fujiwara T, Fujiwara H. Celiprolol, a selective beta1-blocker, reduces the infarct size through production of nitric oxide in a rabbit model of myocardial infarction. Circ J 2007 71 : 574 579.
8. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano DT. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998 88 : 7 17. (Pubitemid 128721126)
9. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999 341 : 1789 1794.
10. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P, POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008 371 : 1839 1847.
11. Lange M, Smul TM, Redel A, Lotz C, Jazbutyte V, Schnupp V, Roewer N, Kehl F. Differential role of calcium/calmodulin-dependent protein kinase II in desflurane-induced preconditioning and cardioprotection by metoprolol: metoprolol blocks desflurane-induced preconditioning. Anesthesiology 2008 109 : 72 80.
12. Lange M, Smul TM, Blomeyer CA, Redel A, Klotz KN, Roewer N, Kehl F. Role of the beta-1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo. Anesthesiology 2006 105 : 503 510.
13. Boost KA, Flondor M, Hofstetter C, Platacis I, Stegewerth K, Hoegl S, Nguyen T, Muhl H, Zwissler B. The beta-adrenoceptor antagonist propranolol counteracts anti-inflammatory effects of isoflurane in rat endotoxemia. Acta Anaesthesiol Scand 2007 51 : 900 908.
14. Pollesello P, Papp Z. The cardioprotective effects of levosimendan: preclinical and clinical evidence. J Cardiovasc Pharmacol 2007 50 : 257 263.
15. Bienengraeber MW, Weihrauch D, Kersten JR, Pagel PS, Warltier DC. Cardioprotection by volatile anesthetics. Vascul Pharmacol 2005 42 : 243 252.
16. Oksanen T, Hynynen M. Perioperative β-blockade: time to change the paradigm? Acta Anaesthesiol Scand 2009 53 : 553 555.
17. Metzsch C, Liao Q, Steen S, Algotsson L. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model. Acta Anaesthesiol Scand 2007 51 : 86 93.
18. Metzsch C, Liao Q, Steen S, Algotsson L. Myocardial glycerol release, arrhythmias and hemodynamic instability during regional ischemia-reperfusion in an open chest pig model. Acta Anaesthesiol Scand 2006 50 : 99 107.
19. Iliodromitis EK, Tasouli A, Andreadou I, Bofilis E, Zoga A, Cokkinos P, Kremastinos DT. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo. Eur J Pharmacol 2004 499 : 163 169.
20. Larsen JR, Aagaard SR, Hasenkam JM, Sloth E. Pre-occlusion ischaemia, not sevoflurane, successfully preconditions the myocardium against further damage in porcine in vivo hearts. Acta Anaesthesiol Scand 2007 51 : 402 409.
21. van Bilsen M, van der Vusse GJ, Willemsen PH, Coumans WA, Roemen TH, Reneman RS. Lipid alterations in isolated, working rat hearts during ischemia and reperfusion: its relation to myocardial damage. Circ Res 1989 64 : 304 314.
22. Ye J, Clark MG, Colquhoun EQ. Creatine phosphate as the preferred early indicator of ischemia in muscular tissues. J Surg Res 1996 61 : 227 236.
23. Frykholm P, Hillered L, Långström B, Persson L, Valtysson J, Watanabe Y, Enblad P. Increase of interstitial glycerol reflects the degree of ischaemic brain damage: a PET and microdialysis study in a middle cerebral artery occlusion-reperfusion primate model. J Neurol Neurosurg Psychiatry 2001 71 : 455 461.
24. Ungerstedt U, Rostami E. Microdialysis in neurointensive care. Curr Pharm Des 2004 10 : 2145 2152.
25. Gilbert M, Anderson EA, Brøndbo A, Bjertnaes LJ. Muscle relaxants change myocardial metabolism in patients with ischemic heart disease during high-dose fentanyl anesthesia. Acta Anaesthesiol Scand 1990 34 : 47 54.